As ADCs undergo intracellular processing it is likely that the ADC will only act on the membrane bound GPC-1 protein, however there is potential that the ADC could bind to the soluble fragment found in circulating exosomes, which may limit the availability of ADC to target the tumor. The gene discussed is GPC1; the disease is neoplasm.